Sensex rises 462 points, Nifty at 23,581 as pharma and banking stocks surge
Synopsis
Key Takeaways
Sensex surged as much as 462 points or 0.61% to touch an intraday high of 75,071 on Thursday, 14 May, while the Nifty50 climbed approximately 170 points or 0.72% to trade around 23,581 in early trade. The rally came despite elevated crude oil prices and persisting geopolitical tensions, driven by broad-based buying in pharma, banking, and several other heavyweight sectors.
Sectors Leading the Gains
Buying interest spread across multiple segments, with indices tracking pharma and healthcare, metals, chemicals, banking, energy, cement, and FMCG each gaining over 1%. The breadth of the rally suggests domestic institutional interest rather than a narrow sectoral move.
Notably, Nifty IT bucked the trend, emerging as a top laggard. HCLTech, Infosys, Tata Consultancy Services (TCS), and Tech Mahindra declined up to 1% each, continuing the pressure on technology counters that has persisted through recent sessions.
Volatility and FPI Concerns
The volatility gauge India VIX rose more than 3% to nearly 19, signalling that despite the day's gains, underlying market anxiety remains elevated. According to a market expert, capital is rotating toward markets such as the US, Japan, South Korea, and Taiwan, all of which are currently outperforming.
'As long as the outperformance of these markets and the underperformance of India continue, foreign portfolio investors (FPIs) will continue to sell, which, in turn, will further drag the rupee down,' the expert said.
The analyst flagged that a turnaround would require either the Strait of Hormuz reopening — which would ease crude prices — or a reversal of the AI-driven FPI flow into global tech leaders. 'There is no clarity on when this will happen,' the expert added.
Rupee Depreciation and Its Market Impact
Sustained rupee weakness carries layered consequences for corporate India, the analyst cautioned. Imported inflation is expected to rise, squeezing margins for companies reliant on petroleum-based inputs. Exporters, by contrast, stand to benefit. Pharmaceuticals are seen as a relative safe haven — demand for medicines is relatively inelastic, and the sector gains from a weaker rupee. Textiles are also expected to benefit.
The IT sector, despite being a structural beneficiary of rupee depreciation through dollar-denominated revenues, is reportedly facing additional headwinds from what the analyst described as the 'Anthropic shock' — a reference to competitive disruption in the AI space — keeping the sector under continued pressure.
Global Cues: Crude, Asia, and Wall Street
On the commodities front, international benchmark Brent crude rose 0.52% to $106.18 per barrel, while US West Texas Intermediate (WTI) gained 0.71% to $101.74. Elevated crude remains a key macro risk for India, a major oil importer.
Asian markets showed a mixed picture: Japan's Nikkei traded flat, while Hong Kong's Hang Seng and South Korea's KOSPI edged higher. Indonesia's Jakarta Composite and China's Shanghai Composite declined up to 2%. Overnight on Wall Street, the S&P 500 gained 0.59% and the Nasdaq closed 1.2% higher, providing a supportive global backdrop for Thursday's session.
With crude above $100 per barrel and FPI outflows unresolved, the durability of Thursday's rally will depend on how quickly domestic fundamentals can offset global headwinds.